Melinda Hsu is an Oncology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 72 publications with 744 citations (h-index 12); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-3951Provider last certified this registry record 11 Jan 2023.
Clinical trials
- Pulmonary Rehabilitation in Advanced Lung Cancer Survivors
Sponsor: Case Comprehensive Cancer Center
- ECM and Monitoring w/ Alio Smart Patch in Cancer Pts Receiving Chemotherapy
Sponsor: Case Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20259 payments$10,816openpaymentsdata.cms.gov ↗
- Takeda Pharmaceuticals U.S.A., Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Survivorship-focused content at the American Society of Clinical Oncology (ASCO) 2022-2024 annual meetings.
Journal of Clinical Oncology
2026 - EPR26-163: The Epidemiology of Second Primary Lung Cancer: An Analysis of the Surveillance, Epidemiology, and End Results (SEER) Program
Journal of the National Comprehensive Cancer Network
2026 - Brief Report: Real-World Outcomes in Patients Living With Human Immunodeficiency Virus and Lung Cancer Treated With Immune Checkpoint Inhibitors
JTO Clinical and Research Reports
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”